ALEXANDRIA, Va., June 16 -- United States Patent no. 12,306,184, issued on May 20, was assigned to EUROIMMUN Medizinische Labordiagnostika AG (Luebeck, Germany).
"Biomarkers of membranous glomerulonephritis" was invented by Rolf Stahl (Hamburg, Germany), Elion Hoxha (Hamburg, Germany) and Linda Reinhard (Hamburg, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "Netrin G1 is disclosed as a biomarker of membranous glomerulonephritis (MGN). Netrin G1 antigen-comprising polypeptides and Netrin G1 antibodies can be used in in vitro methods and kits for diagnosis, prognosis and monitoring of MGN of patients with circulating Netrin G1 autoantibodies."
The patent was filed on Oct. 13, 2022, under Application ...